AbbVie’s biggest deal since 2019 could land soon
AbbVie (ABBV) is closing in on a deal to buy Apogee Therapeutics for $10.9 billion in cash, according to a Reuters report citing
AbbVie (ABBV) is closing in on a deal to buy Apogee Therapeutics for $10.9 billion in cash, according to a Reuters report citing
Google DeepMind is treating its most advanced AI agents the same way a security team treats an employee with sensitive access: as a
Building a retirement strategy often involves years of careful planning, consistent contributions, and ongoing portfolio management. But Vanguard is raising a concern that
Morgan Housel has sold 12 million books telling people that investing success comes down to behavior more than analysis. So when he sat
Three days. That’s how long the peace deal Trump and Iranian President Masoud Pezeshkian signed on June 17 lasted before Iran’s military command
President Donald Trump has been trading health care stocks unusually frequently in 2026. Across the first three months of the year, his accounts
Google stock investors were, for the most part, bracing for another AI spending headache. For some context, the tech giant had already bumped
The USD/JPY exchange rate continued its strong rally last week, reaching its highest point since 1986. It peaked at 161.81, up by 15%
The popular silver thesis says a record sixth-straight supply deficit makes higher prices a near-certainty. That is the wrong way to read this
On June 18, Cathie Wood’s ARK Invest showed off a notable rotation following a superb run in two of the most popular high-growth